Osteoporosis drugs on every 2026 Connecticut Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 11 stand-alone Part D plans in Connecticut cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
11 plans, cheapest premium first. Scroll sideways for all of them →
| Drug | Humana Basic Rx Plan$8.40/moS5884-102 | Wellcare Value Script$16.40/moS4802-137 | Blue MedicareRx Value Plus$20.70/moS2893-001 | Wellcare Classic$21.70/moS4802-076 | SilverScript Choice$32.70/moS5601-004 | AARP Medicare Rx Saver from UHC$38.70/moS5921-348 | Humana Value Rx Plan$73.60/moS5884-182 | Humana Premier Rx Plan$138.60/moS5884-149 | HealthSpring Assurance Rx$139.30/moS5617-008 | AARP Medicare Rx Preferred from UHC$155.10/moS5921-385 | Blue MedicareRx Premier$238.60/moS2893-003 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| alendronategeneric Fosamax | Tier 2$1.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$0.00 | Tier 1$0.00QL 30/30d | Tier 1$2.00 | Tier 2$8.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$5.00QL 30/30d | Tier 1$1.00 |
| risedronategeneric Actonel | Not covered | Tier 2$3.00QL 1/30d | Not covered | Not covered | Tier 1$2.00QL 1/28d | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| ibandronategeneric Boniva | Tier 325%QL 1/28d | Tier 2$3.00QL 1/30d | Tier 3PA17% | Tier 325%QL 1/30d | Tier 1$2.00QL 1/30d | Tier 317%QL 1/28d | Tier 318%QL 1/28d | Tier 3$45.00QL 1/28d | Tier 321%QL 1/28d | Tier 315%QL 1/28d | Tier 2PA$7.00 |
| Proliadenosumab | Tier 432%QL 1/180d | Not covered | Tier 432%QL 1/180d | Not covered | Not covered | Not covered | Tier 431%QL 1/180d | Tier 450%QL 1/180d | Tier 431%QL 1/180d | Not covered | Tier 435%QL 1/180d |
| denosumab biosimilarsJubbonti, Ospomyv and others | Not covered | Tier 440%QL 1/180d | Tier 432%QL 1/180d | Tier 429%QL 1/180d | Tier 435%QL 1/180d | Tier 435%QL 1/180d | Not covered | Not covered | Not covered | Tier 430%QL 1/180d | Tier 435%QL 1/180d |
| Evenityromosozumab | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| Forteoteriparatide | Tier 5PA25%QL 2.24/28d | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 5PA26%QL 2.24/28d | Tier 5PA33%QL 2.24/28d | Not covered | Not covered | Not covered |
| teriparatidegeneric Forteo | Not covered | Tier 5PA25%QL 2.48/28d | Tier 5PA25%QL 2.48/28d | Tier 5PA25%QL 2.48/28d | Tier 5PA25% | Tier 5PA25%QL 2.48/28d | Not covered | Not covered | Tier 5PA25%QL 2.48/28d | Tier 5PA31%QL 2.48/28d | Tier 5PA33%QL 2.48/28d |
| Tymlosabaloparatide | Not covered | Not covered | Tier 5PA25%QL 1.56/30d | Not covered | Tier 5PA25% | Not covered | Not covered | Not covered | Not covered | Tier 5PA31%QL 1.56/30d | Tier 5PA33%QL 1.56/30d |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.